Gracell Biotechnologies Inc. (GRCL)
US$ 10.250.05%
Price Chart
Key Statistics
Market Cap
$ 989.87M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
6.42M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
-0.34
Technicals
50-Day MA
9.5389
200-Day MA
5.2413
52 Week High
N/A
52 Week Low
N/A
About GRCL
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China.
Employees
314
Headquarters
Suzhou, China
CEO
Dr. Wei Cao BM, Ph.D.
Latest News
Plans to repurpose Kildare retail unit for residential use - Kildare Now
4 days ago • Google News
Gracell Biotechnologies Acquisition Completed - Stock Titan
2024-02-22 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg